Fig. 3From: KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation dataQuantitative real-time PCR analysis the expression of KAZN in human ovarian cancer tissues and normal ovarian tissues. ΔCt was used to determine the relative amounts of mRNA. There is Significant difference in 8 normal ovarian tissues and 6 tumor tissues by ANOVA statistical test, p = 0.0087Back to article page